Lupride 45mg Injection

• Prostate cancer
• Endometriosis
• Uterine fibroids
• Precocious puberty (premature puberty)

Most side effects of Lupride 45mg Injection do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Common side effects include:

• Decreased libido
• Testicular atrophy
• Increased sweating
• Fatigue
• Muscle weakness
• Erectile dysfunction
• Hot flashes

• Lupride 45mg is available in injection form and is advised to be taken as per the doctor's prescription. It usually given under the skin (subcutaneous) by a doctor or nurse under strict medical supervision.Taking this injection in the wrong way may give you severe side effects.
• In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects. So, it is always advisable to follow the prescription of the doctor strictly.​​
  

• Lupride 45mg Injection is a prescription based medicine with Leuprolide Asetate as an active ingredient. It works by lowering male testosterone levels in the blood.
• Additionally, this injection lowers the quantity of estrogen, one of the hormones that causes women to have periods, by blocking hormones produced by the ovaries, a female reproductive organ.
• In this way, it works by interfering with the hormones production & action in both female or male depends on the type of condition being treated.​
  

• Donnez, J., Tomaszewski, J., Vázquez, F., Bouchard, P., Lemieszczuk, B., Baró, F., ... & Loumaye, E. (2012). Ulipristal acetate versus leuprolide acetate for uterine fibroids. New England Journal of Medicine, 366(5), 421-432. https://pubmed.ncbi.nlm.nih.gov/22296076/
• Klein, K. O., Mauras, N., Nayak, S., Sunil, B., Martinez-Placencia, B. M., Dragnic, S., ... & Kansra, A. R. (2023). Efficacy and safety of leuprolide acetate 6-month depot for the treatment of central precocious puberty: a phase 3 study. Journal of the Endocrine Society, 7(7), bvad071. https://pubmed.ncbi.nlm.nih.gov/37334213/
• Dlugi, A. M., Miller, J. D., Knittle, J., & Lupron Study Group. (1990). Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Fertility and sterility, 54(3), 419-427. https://pubmed.ncbi.nlm.nih.gov/2118858/
• Persad, R. (2002). Leuprorelin acetate in prostate cancer: a European update. International journal of clinical practice, 56(5), 389-396.
• Lacroix, A., Hamet, P., & Boutin, J. M. (1999). Leuprolide acetate therapy in luteinizing hormone–dependent Cushing's syndrome. New England Journal of Medicine, 341(21), 1577-1581.